US Stock MarketDetailed Quotes

APGE Apogee Therapeutics

Watchlist
  • 44.700
  • +0.740+1.68%
Close Nov 27 16:00 ET
  • 44.700
  • 0.0000.00%
Post 20:01 ET
2.62BMarket Cap-17339P/E (TTM)

About Apogee Therapeutics Company

Apogee Therapeutics, Inc. operates as a biotechnology company. It offers treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD) and related inflammatory and immunology (I&I) indications. The company was founded in 2022 and is headquartered in Waltham, MA.

Company Profile

SymbolAPGE
Company NameApogee Therapeutics
Listing DateJul 14, 2023
Issue Price17.00
Founded2022
CEODr. Michael Henderson, M.D.
MarketNASDAQ
Employees91
Fiscal Year Ends12-31
Address221 Crescent Street,Building 17, Suite 102b
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02453
Phone1-650-394-5230
Websitehttp://www.apogeetherapeutics.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Michael Henderson, M.D.
  • Chief Executive Officer and Director
  • 1.17M
  • Jane Pritchett Henderson
  • Chief Financial Officer and Chief Accounting Officer
  • 1.72M
  • Dr. Carl Dambkowski, M.D.
  • Chief Medical Officer
  • 870.83K
  • Mark C. McKenna
  • Chairman of the Board
  • 972.87K
  • Dr. Lisa L. Bollinger, M.D.
  • Director
  • --
  • William B.J. Jones, Jr
  • Independent Director
  • 411.66K
  • Tomas Kiselak
  • Independent Director
  • 662.82K
  • Peter Harwin
  • Independent Director
  • 668.57K
  • Nimish Shah
  • Independent Director
  • 664.82K
  • Jennifer A. Fox
  • Independent Director
  • 414.57K
  • Dr. Andrew Gottesdiener, M.D.
  • Independent Director
  • 666.57K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data